SPECIAL NOTICE
A -- RRPV Solicitation Summary: COVID-19 Monoclonal Antibody Therapeutics for Treatment
- Notice Date
- 2/21/2024 4:31:24 PM
- Notice Type
- Special Notice
- NAICS
- 541714
— Research and Development in Biotechnology (except Nanobiotechnology)
- Contracting Office
- BARDA - ASPR / DAAPPO / BARDA DCMA WASHINGTON DC 20515 USA
- ZIP Code
- 20515
- Solicitation Number
- RPP-24-03-Treatment
- Response Due
- 4/8/2024 10:00:00 AM
- Archive Date
- 04/23/2024
- Point of Contact
- Rebecca Harmon
- E-Mail Address
-
rebecca.harmon@ati.org
(rebecca.harmon@ati.org)
- Description
- This solicitation summary is to notify all potential offerors of a Request for Project Proposals (RPP) issued through the Rapid Response Partnership Vehicle (RRPV) Consortium on behalf of Biomedical Advanced Research and Development Authority (BARDA) entitled ""COVID-19 Monoclonal Antibody Therapeutics for Treatment"". The full RPP and information on joining the consortium can be accessed through the RRPV website www.rrpv.org. Thank you for your interest in this requirement.
- Web Link
-
SAM.gov Permalink
(https://sam.gov/opp/6adaaeb52894454f9ac4e5909dd1f6c7/view)
- Place of Performance
- Address: Washington, DC, USA
- Country: USA
- Country: USA
- Record
- SN06971634-F 20240223/240221230043 (samdaily.us)
- Source
-
SAM.gov Link to This Notice
(may not be valid after Archive Date)
| FSG Index | This Issue's Index | Today's SAM Daily Index Page |